Prediction of lateral pelvic lymph node metastasis in patients with locally advanced rectal cancer with preoperative chemoradiotherapy: Focus on MR imaging findings
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Min Ju | - |
dc.contributor.author | Hur, Bo Yun | - |
dc.contributor.author | Lee, Eun Sun | - |
dc.contributor.author | Parka, Boram | - |
dc.contributor.author | Joo, Jungnam | - |
dc.contributor.author | Kim, Min Jung | - |
dc.contributor.author | Park, Sung Chan | - |
dc.contributor.author | Baek, Ji Yeon | - |
dc.contributor.author | Chang, Hee Jin | - |
dc.contributor.author | Kim, Dae Yong | - |
dc.contributor.author | Oh, Jae Hwan | - |
dc.date.available | 2019-03-07T04:45:42Z | - |
dc.date.issued | 2018-04 | - |
dc.identifier.issn | 1932-6203 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/2273 | - |
dc.description.abstract | Purpose To investigate the predictive factors for lateral pelvic lymph node (LPLN) metastasis in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy (CRT). Materials and methods Fifty-seven patients with locally advanced rectal cancer and LPLNs larger than 5 mm underwent LPLN dissection (LPLD) after preoperative CRT. The MRI findings, including the apparent diffusion coefficient value and LPLN size reduction rate before/after CRT; clinical factors; and pathologic results were evaluated to identify the predictive factors associated with LPLN metastasis. Results LPLN metastasis was confirmed in 23 patients (40.4%). Metastasis was significantly higher in LPLNs with multiplicity, short-axis diameter >= 8 mm before CRT, short-axis diameter >5 mm after CRT, size reduction rate <= 33.3%, heterogeneous signal intensity, and irregular margin (P<0.05) on MR. Multivariable analysis showed that pre-CRT short-axis diameter of LPLNs >= 8 mm, size reduction rate <= 33.3%, and heterogeneous signal intensity were independently associated with LPLN metastasis. Conclusions The size and signal intensity of LPLN before and after CRT are useful MRI findings to predict LPLN metastasis and are helpful to determine the indications for LPLD. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | PUBLIC LIBRARY SCIENCE | - |
dc.title | Prediction of lateral pelvic lymph node metastasis in patients with locally advanced rectal cancer with preoperative chemoradiotherapy: Focus on MR imaging findings | - |
dc.type | Article | - |
dc.identifier.doi | 10.1371/journal.pone.0195815 | - |
dc.identifier.bibliographicCitation | PLOS ONE, v.13, no.4 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000429791900093 | - |
dc.identifier.scopusid | 2-s2.0-85045431622 | - |
dc.citation.number | 4 | - |
dc.citation.title | PLOS ONE | - |
dc.citation.volume | 13 | - |
dc.type.docType | Article | - |
dc.publisher.location | 미국 | - |
dc.subject.keywordPlus | TOTAL MESORECTAL EXCISION | - |
dc.subject.keywordPlus | APPARENT DIFFUSION-COEFFICIENT | - |
dc.subject.keywordPlus | RADIATION-THERAPY | - |
dc.subject.keywordPlus | CHEMORADIATION THERAPY | - |
dc.subject.keywordPlus | PERITONEAL REFLECTION | - |
dc.subject.keywordPlus | COLORECTAL-CANCER | - |
dc.subject.keywordPlus | CARCINOMA | - |
dc.subject.keywordPlus | DISSECTION | - |
dc.subject.keywordPlus | CHEMOTHERAPY | - |
dc.subject.keywordPlus | INVOLVEMENT | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.relation.journalWebOfScienceCategory | Multidisciplinary Sciences | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.